Natural Killer cell recognition of melanoma: new clues for a more effective immunotherapy

Natural killer cells participate in the early immune response against melanoma and also contribute to the development of an adequate adaptive immune response by their crosstalk with dendritic cells and cytokine secretion. Melanoma resistance to conventional therapies together with its high immunogen...

Full description

Bibliographic Details
Main Authors: Raquel eTarazona, Esther eDuran, Rafael eSolana
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00649/full
_version_ 1828768917553676288
author Raquel eTarazona
Esther eDuran
Rafael eSolana
author_facet Raquel eTarazona
Esther eDuran
Rafael eSolana
author_sort Raquel eTarazona
collection DOAJ
description Natural killer cells participate in the early immune response against melanoma and also contribute to the development of an adequate adaptive immune response by their crosstalk with dendritic cells and cytokine secretion. Melanoma resistance to conventional therapies together with its high immunogenicity justifies the development of novel therapies aimed to stimulate effective immune responses against melanoma. However, melanoma cells frequently escape to CD8 T cell recognition by the down-regulation of major histocompatibility complex class I molecules. In this scenario, Natural killer cells emerge as potential candidates for melanoma immunotherapy due to their capacity to recognize and destroy melanoma cells expressing low levels of major histocompatibility complex class I molecules. In addition, the possibility to combine immune checkpoint blockade with other NK cell potentiating strategies (e.g. cytokine induction of activating receptors) has opened new perspectives in the potential use of adoptive NK cell-based immunotherapy in melanoma.
first_indexed 2024-12-11T13:38:25Z
format Article
id doaj.art-06df6f72458f4b38b2da22528dda39c6
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-11T13:38:25Z
publishDate 2016-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-06df6f72458f4b38b2da22528dda39c62022-12-22T01:04:54ZengFrontiers Media S.A.Frontiers in Immunology1664-32242016-01-01610.3389/fimmu.2015.00649173498Natural Killer cell recognition of melanoma: new clues for a more effective immunotherapyRaquel eTarazona0Esther eDuran1Rafael eSolana2University of ExtremaduraUniversity of ExtremaduraIMIBIC- Reina Sofia University Hospital-University of CordobaNatural killer cells participate in the early immune response against melanoma and also contribute to the development of an adequate adaptive immune response by their crosstalk with dendritic cells and cytokine secretion. Melanoma resistance to conventional therapies together with its high immunogenicity justifies the development of novel therapies aimed to stimulate effective immune responses against melanoma. However, melanoma cells frequently escape to CD8 T cell recognition by the down-regulation of major histocompatibility complex class I molecules. In this scenario, Natural killer cells emerge as potential candidates for melanoma immunotherapy due to their capacity to recognize and destroy melanoma cells expressing low levels of major histocompatibility complex class I molecules. In addition, the possibility to combine immune checkpoint blockade with other NK cell potentiating strategies (e.g. cytokine induction of activating receptors) has opened new perspectives in the potential use of adoptive NK cell-based immunotherapy in melanoma.http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00649/fullAdoptive TransferImmunotherapyMelanomacheckpoint blockadeNatural Killer cells
spellingShingle Raquel eTarazona
Esther eDuran
Rafael eSolana
Natural Killer cell recognition of melanoma: new clues for a more effective immunotherapy
Frontiers in Immunology
Adoptive Transfer
Immunotherapy
Melanoma
checkpoint blockade
Natural Killer cells
title Natural Killer cell recognition of melanoma: new clues for a more effective immunotherapy
title_full Natural Killer cell recognition of melanoma: new clues for a more effective immunotherapy
title_fullStr Natural Killer cell recognition of melanoma: new clues for a more effective immunotherapy
title_full_unstemmed Natural Killer cell recognition of melanoma: new clues for a more effective immunotherapy
title_short Natural Killer cell recognition of melanoma: new clues for a more effective immunotherapy
title_sort natural killer cell recognition of melanoma new clues for a more effective immunotherapy
topic Adoptive Transfer
Immunotherapy
Melanoma
checkpoint blockade
Natural Killer cells
url http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00649/full
work_keys_str_mv AT raqueletarazona naturalkillercellrecognitionofmelanomanewcluesforamoreeffectiveimmunotherapy
AT esthereduran naturalkillercellrecognitionofmelanomanewcluesforamoreeffectiveimmunotherapy
AT rafaelesolana naturalkillercellrecognitionofmelanomanewcluesforamoreeffectiveimmunotherapy